So much is wrong with this misleading thread.
The thread title clearly and misleadingly infers that marketing approval for Viraleze has been given whereas in reality land, the TGA is yet to make a decision which is up to 8 weeks away.
And then the chief pumper chimes in with:
’Targeting baby boomers on cruise ships would be an ideal cohort for Viraleze’
Sorry to break it to you captain, but the world’s largest baby boomer consumer market for cruise ships is Europe. Viraleze has been approved and marketed in this market since 2021 with peanuts to show for it.
Starpharma have missed this boat. And to add an extra sting in the face, long suffering shareholders have paid for it. $2.50 to 8.6 cents is quite the voyage.
ARTG Astodrimer sodium Nasal Spray to be included by September, page-9
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.31M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.9¢ | $14.97K | 151.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 372123 | 9.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 5042 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| SPL (ASX) Chart |